CellBox Labs – Organ-on-Chip Innovation for European Strategic Autonomy
Cellbox Labs is pioneering a European organ-on-chip platform that replicates human tissues (e.g. gut, lung, pancreas) on microfluidic chips. These biomimetic devices integrate living cells in fluidic channels to recreate organ functions, offering a novel alternative to animal testing. The technology’s key features—custom polymers for realistic physiological environments, integrated oxygen and pH sensors, and automated fluidic control—enable personalized drug and toxicity testing in vitro. By combining such hardware with AI-driven “digital twin” models, Cellbox Labs aims to produce rich predictive data for pharmaceuticals. This blend of engineering and biotechnology positions the company at the cutting edge of health-tech innovation, aligning with EU life-science objectives and sparking interest from both researchers and investors. The result is an ambitious startup-based capability in Europe’s biotech sector, hinting at new ways the continent can secure its drug development and defense-health capabilities.